AveXis continues in cooperation with ExCEEd Orphan in North Macedonia for Zolgensma®, the
Tag: news
AveXis receives EC approval for Zolgensma®
AveXis receives EC approval and activates “Day One” access program for Zolgensma®, the
First SMA Patient in Czechia was treated with gene therapy in Faculty Hospital in Motol
Little Max is the first patient with spinal muscular atrophy who received systemic
Gene Therapy reimbursed for SMA patients in Czechia
Czech Health Insurance companies recently approved reimbursement of breakthrough gene therapy treatment for
Eurodis and Covid 19 Pandemic
April 8, 2020 EURORDIS open letter to policy makers: Recommendations to protect people
Kyowa Kirin cooperation extended
April 1, 2020 The company ExCEEd Orphan announces its consulting cooperation expansion with
AveXis receives positive CHMP opinion for Zolgensma®
AveXis receives positive CHMP opinion for Zolgensma®, the only gene therapy for spinal
Novartis receives approval from Japanese Ministry of Health, Labour and Welfare for Zolgensma®
Novartis receives approval from Japanese Ministry of Health, Labour and Welfare for Zolgensma®
Rare Disease Day support
ExCEEd Orphan is honoured and engaged to support Rare Disease Day campaign and